Lensar (LNSR) Shares Outstanding (Diluted Average) (2021 - 2026)
Lensar (LNSR) reported Shares Outstanding (Diluted Average) of $15.4 million for Q1 2026, up 30.97% year-over-year from $11.8 million in Q1 2025, and up 28.95% quarter-over-quarter from $12.0 million in Q4 2025.
Lensar (LNSR) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends
Lensar (LNSR) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $15.4 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $15.4 million, up 30.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.4 million (up 30.97% YoY), and the FY2025 annual result was $12.0 million, up 3.82% from the prior year.
- Shares Outstanding (Diluted Average) rose to $15.4 million in Q1 2026 per LNSR's latest filing, from $12.0 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $15.4 million in Q1 2026 and troughed at $10.0 million in Q1 2022.
- A 5-year average of $11.4 million and a median of $11.4 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Diluted Average) increased 2.72% in 2025, then jumped 30.97% in 2026.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $10.2 million in 2022, then rose by 7.99% to $11.0 million in 2023, then grew by 4.99% to $11.5 million in 2024, then increased by 3.82% to $12.0 million in 2025, then increased by 28.95% to $15.4 million in 2026.
- Business Quant data shows LNSR's Shares Outstanding (Diluted Average) at $15.4 million in Q1 2026, $12.0 million in Q4 2025, and $11.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | 15.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.42 Mn |
| Dec 31, 2025 | 11.96 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Jun 30, 2025 | 11.86 Mn |
| Mar 31, 2025 | 11.77 Mn |
| Dec 31, 2024 | 11.52 Mn |
| Sep 30, 2024 | 11.60 Mn |
| Jun 30, 2024 | 11.42 Mn |
| Mar 31, 2024 | 11.39 Mn |
| Dec 31, 2023 | 10.97 Mn |
| Jun 30, 2023 | 10.82 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 10.16 Mn |
| Sep 30, 2022 | 10.23 Mn |
| Jun 30, 2022 | 10.02 Mn |
| Mar 31, 2022 | 9.97 Mn |
| Dec 31, 2021 | 9.37 Mn |
| Sep 30, 2021 | 9.44 Mn |
| Jun 30, 2021 | 9.24 Mn |